Dr. Janine Schuurman is an expert in antibody biology and translational research. Following her passion to develop innovative antibody therapeutics, Dr. Schuurman joined Genmab in 2000. She currently serves in the position of Corporate Vice President Research & Innovation in which she heads Research and Technologies, focusing on antibody biology research, the creation of novel antibody formats and their translation to antibody therapeutics. She is a co-inventor of the DuoBody®, HexaBody® and HexElect® technologies that enable the generation of bispecific and effector-function enhanced antibodies. These technologies are being applied to antibody therapeutics discovery programs at Genmab, as well as many leading pharmaceutical and biotechnology companies located worldwide.
You are here: / / / Janine Schuurman, Ph.D.